Dual-Target Lymphatic Embolization for Refractory Chylous Ascites After Nephroureterectomy
Abstract We report a case of refractory chylous ascites following nephroureterectomy and para-aortic lymphadenectomy for renal pelvic carcinoma, which was successfully treated with percutaneous lymphatic embolization. An 83-year-old man underwent nephroureterectomy with para-aortic lymph node dissection for renal pelvic carcinoma. Postoperatively, > 1000 mL/day of chylous ascites was continuously drained. Despite conservative management, high-output ascites persisted. Transnodal lymphangiography via the inguinal lymph nodes and post-lymphangiographic computed tomography (CT) revealed lymphatic leakage at the nephroureterectomy site. Percutaneous lymphatic embolization was planned as a minimally invasive procedure. Under CT guidance, embolization of a lymphopseudoaneurysm and para-aortic lymph nodes near the leakage site was successfully performed using N-butyl cyanoacrylate. Ascitic fluid output decreased significantly postoperatively, and the drainage tube was removed the following day. This case highlights the importance of post-lymphangiographic CT in identifying actionable lymphatic targets and demonstrates that an anatomically tailored dual-target embolization strategy can achieve effective sealing when central duct access is not feasible.
Authors
- T Ogawa
- Masayuki Kurokawa (ORCID: https://orcid.org/0000-0002-6901-6735)
- Hiroyuki Fujii (ORCID: https://orcid.org/0000-0001-6390-2843)
- Satoshi Ando (ORCID: https://orcid.org/0000-0001-9964-1219)
- Harushi Mori (ORCID: https://orcid.org/0000-0003-1370-5272)
- Tetsuya Fujimura (ORCID: https://orcid.org/0000-0002-3421-8273)
- Soichiro Kojima
- Ryoma Kobayashi
- Toru Sugihara
- Mitsuru Matsuki
- Emiko Chiba
- Kohei Hamamoto
Institutions
- Jichi Medical University (JP)
Publication Details
- Journal
- BJR|case reports
- Published
- 2026-08-25
- DOI
- https://doi.org/10.1093/bjrcr/uaag038
- Primary Topic
- Lymphatic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00